Synapse - American Society of Hematology

Results (5555)

Outcomes of therapies following discontinuation of non-covalent Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia and Richter transformation: Results from an international, multicenter study

Meeting Abstract

Thompson, M. C.; Bhat, S. A.; Jurczak, W.; Patel, K.; Shah, N. N.; Woyach, J. A.; Coombs, C. C.; Eyre, T. A.; Danecki, M.; Dlugosz-Danecka, M.; more...
Blood (2024)

Fulltext@MSK | Save

Enhanced prognostic value of the SKY92 classifier over high-risk cytogenetic aberrations in multiple myeloma: Results from the Prommis real-world study

Meeting Abstract

Biran, N.; Dhakal, B.; Niesvizky, R.; Lentzsch, S.; McKay, J.; Vesole, D. H.; Nooka, A. K.; Paul, B.; Hari, P. N.; D'Ambrosi, S.; more...
Blood (2024)

Fulltext@MSK | Save

Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)

Meeting Abstract

Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
Blood (2024)

Fulltext@MSK | Save

Inflammation-based scores predict survival after CD3xCD20 bispecific T cell engagers in R/R LBCL

Meeting Abstract

Magno, G.; Rejeski, K.; Rappa, G.; Kupf, S.; Stock, S.; Holzem, A. M. E.; Scholz, J. K.; Wurm-Kuczera, R.; Harlev, S.; Kutsch, N.; more...
Blood (2024)

Fulltext@MSK | Save

Devimistat results in a low complete remission rate in heavily pre-treated Burkitt lymphoma

Meeting Abstract

Steiner, R.; Nikolaenko, L.; Kambhampati, S.; Khan, N.; Nair, R.; Abramson, J. S.; Horwitz, S.; Matasar, M.; Owens, C.; Rodriguez Rivera, I. I.; more...
Blood (2024)

Fulltext@MSK | Save

Genomic characterization and classification of BCL6 rearranged follicular lymphomas

Meeting Abstract

Amallraja, A.; Gundem, G.; Domenico, D.; Ossa, J. E. A.; Aypar, U.; Baik, J.; Kluk, M.; Sethi, S.; Lopez, K.; Qualls, D. A.; more...
Blood (2024)

Fulltext@MSK | Save

NPM::ALK transcript levels and anti-ALK autoantibody titers as biomarkers for outcome in pediatric ALK plus anaplastic large cell lymphoma treated with brentuximab vedotin or crizotinib in combination with chemotherapy: COG ANHL12P1

Meeting Abstract

Forlenza, C. J.; Hoogstra, D.; Barkauskas, D.; Saguilig, L.; Turner, S. D.; Prokoph, N.; Pucci, P.; Hare, L.; Jahangiri, L.; Wu, R.; more...
Blood (2024)

Fulltext@MSK | Save

High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease

Meeting Abstract

Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
Blood (2024)

Fulltext@MSK | Save

Subsequent treatment and clinical outcome following induction therapy on a phase II study of oral azacitidine plus CHOP for peripheral T-cell lymphoma (PTCL)